0001513162-18-000218.txt : 20180827 0001513162-18-000218.hdr.sgml : 20180827 20180824205033 ACCESSION NUMBER: 0001513162-18-000218 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180822 ITEM INFORMATION: Other Events FILED AS OF DATE: 20180827 DATE AS OF CHANGE: 20180824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMERICA INC CENTRAL INDEX KEY: 0000073290 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 952645573 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37863 FILM NUMBER: 181037987 BUSINESS ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9496452111 MAIL ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19871130 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19830216 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC DATE OF NAME CHANGE: 19720508 8-K 1 form8k.htm FORM 8-K Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C.

 

FORM 8-K

 

CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

          August 22, 2018         

Date of Report (date of earliest event reported)

 

 

BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

0-8765

95-2645573

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

 

 

17571 Von Karman Ave. Irvine, California 92614

 

 

(Address of Principal Executive Offices Including Zip Code)

 

 

949-645-2111

 

(Registrant’s Telephone Number, Including Area Code)

 

 

 

(Former Name or Former Address if Changed Since Last Report)

 

1

 

 

Item 8.01.        Other Events.

 

 

On August 22, 2018, the Company was informed that the Korean Intellectual Property Office (KIPO) issued a Certificate of Patent covering Biomerica’s compositions, devices and methods of IBS sensitivity testing (entitled “COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSIVITY TESTING”). The patent specifically applies to Biomerica’s InFoods® IBS product, which is currently in a clinical study in the U.S.  This patent is the first for the InFoods® patent portfolio, providing patent protection for InFoods® IBS in Korea until November 13, 2035.

 

2

 

 

SIGNATURES

 

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

Biomerica, Inc.

 

 

 

 

Dated:  August 27, 2018

By:

 

/s/ Zackary S. Irani

 

 

 

Zackary S. Irani
Chief Executive Officer

 

3